期刊文献+

CD_(105)及肿瘤组织微血管密度与膀胱移行细胞癌的关系 被引量:1

Study on the correlation of the expressions of CD_(105) and the microvessel density in transitional cell carcinoma of the bladder
下载PDF
导出
摘要 目的:检测CD105在膀胱移行细胞癌组织中的表达及微血管密度,探讨CD105在膀胱移行细胞癌发生、发展、浸润和转移中的作用及相互关系。方法:采用免疫组织化学SP法测定6例膀胱乳头状瘤,30例膀胱移行细胞癌组织CD105的表达及M VD。结果:CD105蛋白在膀胱移行细胞癌无淋巴结转移组和淋巴结转移组中的阳性表达率分别为80%和100%,微血管密度值分别为26.9±5.8和31.7±4.3,两组比较,差异有统计学意义(P<0.05)。CD105蛋白在膀胱移行细胞癌无明显浸润组和浸润组中的阳性表达率分别为47%和82%,微血管密度值分别为21.4±3.6和28.4±4.7,两组比较,差异有统计学意义(P<0.05)。结论:CD105蛋白阳性表达及微血管密度值的高低与膀胱移行细胞癌发生、发展、浸润和转移有关。 Objective To study the expression of CD105 and the microvessel density in the transitional cell carcinoma of the bladder and discuss their correlation in the pathogenesis,development, invasion and metastasis in transitional cell carcinoma of the bladder tissues. Methods Immunohistoehemistry SP method was used to detect the expression and microvessel density of CD105 in 6 tissues of bladder papilloma and in 30 tissues of primary transitional cell carcinoma of bladder.Results The rates of positive expressions of CD105 protein in the tissue of non-metastasis and metastasis were 82%(10/12) and 88%(16/18) respectively. The difference in the two groups had a statistical significance (P〈0. 05). The rates of positive expressions of CD105 protein in the tissue of non-invasion and invasion were 48 % (9/19) and 80 % (14/17) respectively. The difference in the two groups had a statistical significance (P 〈0. 05). Conclusion The over expression of CD105 and microvessel density in transitional cell carcinoma of the bladder is related to pathogenesis,development, invasion and metastasis of transitional cell carcinoma of the bladder.
出处 《实用诊断与治疗杂志》 2006年第6期410-412,共3页 Journal of Practical Diagnosis and Therapy
关键词 膀胱移行细胞癌 CD105 微血管密度值 Transitional cell carcinoma of the bladder CD105 microvessel density
  • 相关文献

参考文献10

  • 1Seon B K, Matsuno F, Haruta Y, et al. Long-lasting complete irr hibition of human solid tumors in SCID mice by targeting err dothelial cells of tumor varsulature with antihuman CD105 immunotoxin[J]. Clin Cancer Res, 1997,3:1031
  • 2Akagi K, Ikeday, Sumiyoshi Y, et al. Estimation of angiogenesis with anti-CD105 immunostaining in the process of colorectal cancer development [J]. Surgery, 2002, 131(1Suppl): S109
  • 3景元明,周士福.CD105标记的微血管密度及血管内皮生长因子在胃癌中的表达[J].河北医学,2004,10(1):1-5. 被引量:9
  • 4Letamendia, Lastres P, Botella L M, et al. Role of endoglin in cellular responses to transforming growth factor-beta. A comparative study with betaglycan[J]. J Biol Chem, 1998, 273(49):33011
  • 5Li C, Hampson I N, HampsonL, et al. CD105 antagonizes the inhibitory signaling of transforming growth factor betal of transforming growth factor betalon human vas cular endothelisl cells [J]. FASEB J, 2000,14(1):55
  • 6Johnston G I, Cook R G, Mcever R P. Cloning of GMP-140, agranule membrane protein of platetes and endothelium: sequence similarity to protein involved in cell adhesion and inflammation[J]. Cell, 1989, 56(6):1033
  • 7Takahashi N, Kavanish -Tabata R, Haba A, et al. Association of serum endoglin with matastisis in patients with colorectal , breast and other solid tumors (VEGF) and its effect of chemotherapy on the serum endoglin [J]. Clin Cancer Res, 2001, 7 (3):524
  • 8Hashimoto M, Ohassma M, Ohinishi A, et al. Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma [J]. Lab Invest,1995, 73(6): 859
  • 9李大林,李杨,李传祖,李梅,王文.CD105和VEGF在大肠癌新生血管中的表达[J].中国普通外科杂志,2003,12(11):815-818. 被引量:10
  • 10Liotta L, Saidel G, Kleierman J, et al. The significance of hematenous tumor cell clumps metastatic process [J]. Cancer Res, 1976, 36 (3):889

二级参考文献21

  • 1Li C , Guo B, Bernabeu C , et al. Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105[J]. Microsc Res Tech, 2001, 52(4) :437 -449.
  • 2Zachary I. Vascular endothelial growth factor [ J ]. Int J Biochem Cell Biol, 1998, 30(11) : 1169 -1174.
  • 3Weidner N , Folkman J , Pozza F, et al. Tumor angiogenesis a new significant and independent prognostic factor in early stage breast carcinoma [J]. Nat Cancer Inst, 1992, 84 (12) :1875 - 1887.
  • 4Ellis LM, Takahashi Y, Liu W, et al. Vascular endothelial growth factor in human colon cancer:biology and therapeutic implications [ J]. Oncologist ,2000,5 (Suppl) 1:11 - 15.
  • 5Abdalla SA, Behzad F, Bsharah S, et al. Prognostic relevance of microvessel density in colorectal tumours [ J ]. Oncol Rep,1999, 6(4) :839 -842.
  • 6Fox SH, Whalen GF, Sanders MM, et al. Angiogenesis in normal tissue adjacent to colon cancer [ J ]. J Surg Oncol,1998, 69(4) : 230 -234.
  • 7Fonsatti E, Dd Vecchio L, Ahomonte M, et al. Endoglinn:An accessory component of the TGF-beta1-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignant [ J ]. J Cell Physiol, 2001,188(1):1 -7.
  • 8Hashimoto M, Ohsawa M, Ohinishi A, et al. Expression of vascular endothelial growth factor and its recepter mRNA in angiosarcoma [J]. Lab Invest, 1995, 73(6) : 859 -863.
  • 9Takahashi N, Kavanishi -Tabata R, Haba A, et al. Association of serum endoglin with matastisis in patients with colorectal,breast, and other solid tumours, and suppressive effect of chemotherapy on the serum endoglin [ J ] . Clin Cancer Res, 2001 , 7(3) :524 -532.
  • 10Josko J, Gwozdz B, Jedrzejowska-Szypulka H, et al. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis[J]. Med Sci Monit, 2000, 6(5):1047- 1052.

共引文献15

同被引文献4

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部